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ABSTRACT The human P-glycoprotein (MDR1/P-gp) is an ATP-binding cassette (ABC) transporter involved in cellular
response to chemical stress and failures of anticancer chemotherapy. In the absence of a high-resolution structure for P-gp, we
were interested in the closest P-gp homolog for which a crystal structure is available: the bacterial ABC transporter MsbA. Here
we present the molecular dynamics simulations performed on the transmembrane domain of the open-state MsbA in a bilayer
composed of palmitoyl oleoyl phosphatidylethanolamine lipids. The system studied contained more than 90,000 atoms and was
simulated for 50 ns. This simulation shows that the open-state structure of MsbA can be stable in a membrane environment and
provides invaluable insights into the structural relationships between the protein and its surrounding lipids. This study reveals
the formation of a semipore-like structure stabilized by two key phospholipids which interact with the hinge region of the protein
during the entire simulation. Multiple sequence alignments of ABC transporters reveal that one of the residues involved in the
interaction with these two phospholipids are under a strong selection pressure speciﬁcally applied on the bacterial homologs
of MsbA. Hence, comparison of molecular dynamics simulation and phylogenetic data appears as a powerful approach to
investigate the functional relevance of molecular events occurring during simulations.
INTRODUCTION
The family of ABC (ATP-binding cassette) proteins is com-
posed of an impressive, and still growing, number of proteins
of various functions and is expressed at every level of the
living kingdom, from bacteria and yeasts to plants and
mammals (1). Most of them are membrane proteins, most
generally devoted to ATP-dependent transports of substrates
of highly various natures, and are thus often referred to as
‘‘trafﬁc ATPases’’. In bacteria, ABC transporters are in-
volved in either cell import of different metabolites or the
efﬂux of antibiotics and exogenous molecules. In mammals,
they are always expelling substrates out of cells, and in man
they are involved in different pathophysiological disorders,
such as Tangier disease (ABC A1) or cystic ﬁbrosis (C7),
and pharmacological processes, such as multidrug resistance
(MDR) or absorption-distribution-elimination (ABC B1, C1,
or G2) (2). The substrates handled by the human ABC
transporters are, as far as they are known, often lipids (ABC
A1, A4, B1, B4, D1, G1, G5, G8) (3) or drugs (B1, C1–6,
G2) (4–6), and sometimes (B1, C1, G2) both of them (7).
Despite their biomedical importance, very limited insights
have been provided into the molecular structures of these
membrane proteins (8). Currently, high resolution structures
have been obtained for a few isolated nucleotidic binding
domains. The entire protein structure has only been obtained
for the bacterial transporters BtuCD (9) and (MsbA)2 (10).
BtuCD is an importer of vitamin B12, a large and hydrophilic
molecule, and is rather atypical for an ABC transporter with
its 20 transmembrane helices. In contrast, MsbA presents
itself as a homodimer with a moderate sequence identity with
the members of the B subfamily of the human ABC proteins,
and it mediates the outward transport of the toxic lipid A but
also of various lipids (11) and even drugs (12,13). This
functional homology makes it an attractive bacterial model
for the multidrug transporter P-glycoprotein (P-gp, ABC
B1), especially considering that P-gp is suspected to work as
a ﬂippase for drugs (14), and this appears indeed the case as
it can handle various lipids (15).
The interest in structural data about MsbA is reinforced
by the report of crystal structures of three different isoforms
from Escherichia coli (10), Vibrio cholera (16), and
Salmonella typhimurium (17), which are proposed to be
different conformations of the enzyme during its catalytic
cycle. However, the E. coli MsbA structure has raised sev-
eral concerns regarding the insertion of its transmembrane
domain in the bilayer (18,19) since the bending of the
intramembrane helices with respect to the membrane plane
would result in an atypical geometry for the ‘‘open’’ con-
formation of the dimer. The investigation of the organization
of the lipid molecules around this unique protein shape is
thus of great interest. In particular, it is desirable to address
the dynamic stability of a phospholipid bilayer in its vicinity,
which conditions the functional relevance of this protein
structure. If such an assembly is stable, the question to
address is how phospholipid molecules can accommodate
the bending of the transmembrane domain of the protein.
In this context, we decided to tackle the question of the
membrane perturbation induced at the molecular level by the
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presence of MsbA in a model lipid bilayer in silico. This
study was designed in relation to the lipid translocase
function exhibited by MsbA, with the perspective of gaining
some insights into its mechanisms of functioning.
Molecular dynamics (MD) simulations (20) offer a pow-
erful way of studying biological macromolecules under
approximately physiological conditions. These simulations
have been extensively applied to the study of biological
membranes (21–23) as well as various membrane-bound
proteins (24–28). Recent advances in computer power have
allowed the simulation of mixed micelles modeling human
bile, with simulation times extending to 150 ns (29). Ad-
vances in simulation procedures and computer power mean
than timescales exceeding 10 ns and large systems of
;100,000 atoms are becoming computationally tractable.
In this study, we report extended MD simulations of E.
coli MsbA. A previous simulation of this protein has been
published (19). However, whereas monomer simulations
revealed themselves stable, the MsbA molecule was unstable
in its dimeric form and showed large structural drifts over the
course of the simulation. Moreover a membrane-mimetic
octane slab was used. The interactions between membrane
proteins and their lipid environment play important roles
in the stability and function of proteins (30). Although
an octane slab can represent a correct membrane-mimetic
environment for cylindrical proteins, it might not be suited
when lipid-protein interactions are critical for protein sta-
bility or when the protein does not possess a simple cylin-
drical shape. In this context, we present a 50-ns simulation of
MsbA embedded in a palmitoyl oleoyl phosphatidylethanol-
amine (POPE) bilayer. For computational tractability reasons
and since our main concern is the organization of lipids
around the protein, only the transmembrane domain of the
protein has been studied. As a result, it is shown that
i), protein secondary/tertiary structure is reasonably stable;
ii), polar headgroups of close lipids in the cytosolic leaf-
let partially invaginate, leading to a semipore formation;
iii), two individualized lipid molecules can interact with the
edge of the protein cavity with a clear speciﬁcity with respect
to bulk phospholipids; and iv), the amino acid involved
in this speciﬁcity has been strongly and speciﬁcally con-
served during the evolution of bacterial MsbA-like ABC
transporters, suggesting an important functional role for
the observed structure.
METHODS
General strategy and characteristics
of the simulation
The simulation of the transmembrane domain of E. coli MsbA inserted in a
POPE bilayer is presented in this study (Table 1). Since the main
components of the natural membrane in which MsbA is found are
phosphatidylethanolamine lipids (31), POPE lipids represent a good
approximation for the membrane environment. The MsbA cavity was ﬁlled
with solvent and the protein was constrained during 16 ns; constraints were
then removed and the system was further examined for 34 ns, therefore
leading to a total simulation time of 50 ns. System preparation involved three
steps: i), protein reconstruction, ii), phospholipid bilayer construction, and
iii) protein and bilayer assembly.
All MD simulations were conducted using the GROMACS v3.2 MD
simulation package (32) with parameter set ffgmx. Production simulations
were performed in the isobaric-isothermal ensemble (NPT). The temperature
of the system was coupled using the Berendsen algorithm (33) at 300 K with
coupling constant tT ¼ 0.1 ps. Protein, phospholipids, solvent, and ions
were coupled separately. The pressure was coupled using the Berendsen
algorithm at 1 bar with coupling constant tP ¼ 2 ps and the compressibility
was set to 4.5 3 105 bar1 in all simulation box directions. Electrostatic
interactions were calculated using particle mesh Ewald (34) with a real space
cutoff of 0.9 nm. Cutoff for van der Waals interactions was set at 0.9 nm.
Time step for integration was 2 fs; coordinates and velocities were saved
every 0.5 ps. The LINCS algorithm was used to restrain bond lengths (35).
Protein reconstruction
The crystallographic structure of the MsbA protein from E. coli (Protein
Data Bank (PDB) code: 1JSQ) was used as a starting structure for our
simulations. The structure only contains an incomplete Ca trace; no side-
chain or backbone atoms other than Ca are present. Several residues are
missing (residues 1–9 and 208–237 for the ﬁrst monomer). The transmem-
brane domain of E. coliMsbA, i.e., residues 1–104, 132–200, and 245–309,
was reconstructed (Fig. 1). The nine N-terminal residue Ca atoms were
reconstructed to form an a-helix with residues 10–20. The other missing
residues (residues 208–237) were not part of the transmembrane domain and
were therefore not reconstructed. Missing backbone and side-chain atoms
were predicted using MAXSPROUT (36) and SCWRL (37). Residues lying
inside the bilayer hydrophobic core were considered neutral. Ionization
states of the protein’s other side chains were the same as the standard at pH 7,
except for buried residues. Buried residues were determined using WHATIF
(38) to calculate accessible solvent area and with visual examination.
Phospholipid bilayer construction
The bilayer contained 662 POPE lipids; it was generated by extending
a preequilibrated bilayer containing 340 lipids (26). The extension was
achieved by replicating the 340 lipids box twice in both directions of the
membrane plane, therefore leading to a 1360 POPE lipids system. Box di-
mensions were then reduced by 70% in the plane of the bilayer, yielding a
system of 669 lipids. Seven lipids from the top layer were then randomly
selected and removed to achieve an equal number of lipids in both layers.
The system was then hydrated using a preequilibrated box of simple point
charge-extended (SPC/E) water (39). The system was subjected to 1000
steps of steepest descent energy minimization. The coordinates of the lipids
were then frozen, allowing the solvent molecules to relax and adapt their
coordinates with the membrane during a 500-ps simulation in the canonical
ensemble (NVT). The system was then equilibrated in a series of 250-ps
simulations in the NPT ensemble with semiisotropic pressure coupling. The
compressibility in the plane of the bilayer was ﬁxed to 4.25 3 105 bar1
and was discretely increased from 1.0 3 1030 bar1 along the bilayer
normal to reach 4.25 3 105 bar1 after 2.25 ns of simulation. The ﬁnal
equilibration run consisted of a 2.5-ns simulation in the NPT ensemble with
a compressibility of 4.25 3 105 bar1 in all directions.
TABLE 1 Simulation summary
Duration (ns) Lipids Waters and ions Atoms Restraints
50 591 POPE 18,601
waters and
14 Na1, 34 Cl
91,271 Protein
backbone:
ﬁrst 16 ns
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Protein and bilayer assembly
The protein was inserted in a preequilibrated POPE bilayer in the fashion
outlined by Sansom et al. (40). The protein was oriented such that its
principal axis of inertia was aligned along the bilayer normal (z axis) and
its other axes of inertia made an angle of 45 with the box axes in the plane
of the bilayer. Positioning along the z axis was such that the bands of
tryptophan residue side chains were located in the lipid headgroup region.
To accommodate the protein, the box dimension along the z-direction was
increased to 7.75 nm, and the system was subsequently hydrated using a
preequilibrated box of SPC/E water (39). The cavity of the protein was ﬁlled
with water. Randomly positioned potassium and sodium ions replaced 48
water molecules to balance the charges on the nonneutral protein residues,
equivalent to a concentration of 17 mM. The size of the simulation box was
13.333 13.213 7.75 nm. The resulting system was equilibrated following
the procedure summarized in Table 2. After initial steepest descents energy
minimization of the system, the protein and lipids coordinates were frozen
to allow solvent molecules to relax their coordinates and optimize their
interactions with the lipid-protein assembly in a 500-ps simulation in the
NVT ensemble. The constraints on lipid molecules were then removed to
optimize lipid-protein interactions in a 500-ps simulation in the NVT
ensemble. The backbone atoms of the resulting system were then frozen,
allowing side-chain atoms to relax their positions and optimize their inter-
actions with lipid and solvent molecules in a 500-ps simulation in the NVT
ensemble. The ﬁnal equilibration step consisted of a 500-ps simulation in the
NPT ensemble where backbone atoms of the protein were restrained
harmonically using a force constant of 1000 kJ mol1 nm2. The resulting
system was used in a 50-ns simulation in the NPT ensemble. In the ﬁrst 16 ns
of this simulation, the protein backbone was restrained harmonically using
a force constant of 1000 kJ mol1 nm2; this restraint was removed for the
remainder of the simulation.
Simulations were analyzed using GROMACS routines and locally
written scripts. Secondary structure was analyzed using DSSP. All molec-
ular graphics representations were generated using Pymol.
Conservation analysis
Given the sequence of the query protein, close homologous sequences were
retrieved from the NR database using Psi-Blast (41). Divergent sequences
leading to gaps or insertion in the transmembrane helices were removed
from the resulting multiple sequence alignment (MSA) to be consistent with
the structure of the protein. After removing any sequence with more than
90% sequence identity to any other as detected using Psi-Blast, a set of 96
sequences was extracted to form the MsbA-like data set.
A phylogenetic tree has been constructed (considering a neighbor joining
method using a BLOSUM62 matrix) with the JALVIEW software (42). The
96 sequences were then divided into two major subgroups according to the
phylogenetic tree: A1, including E. coli MsbA, which contains the closest
homologs of this protein (49 sequences with an average identity of 42%),
and A2, which contains remote homologs of E. coli MsbA (47 sequences
with an average identity of 20%). Two MSAs were thus considered, MSA1,
restricted to Msba functional homologs, and MSA2, gathering the remaining
sequences of ABC transporters retrieved from the Blast procedure. For every
position of MSA1 and MSA2, an evolutionary conservation score was
computed. Conservation scores for each amino acid position in the resulting
MSAs were computed using the rate4site program (43). The Bayesian
method was applied for the calculation of the conservation scores using the
Jones-Taylor-Thornton amino acid substitution model (44). The conserva-
tion scores computed by rate4site are a relative measure of evolutionary
conservation at each position in the MSA: the lowest score represents the
most conserved position in the MSA. Each score S has been rescaled
between 0 and 99 using
Rscore ¼ 99 ð993 ðS LscoreÞ=DscoreÞ;
where Rscore is the rescaled score, Lscore the lowest score, and Dscore the
amplitude of all the scores. The rescaled conservation grades were then
mapped onto the protein by replacing the B factors in the PDB ﬁle. The most
conserved residues correspond to the highest rescaled scores.
The second goal of the phylogenetic analysis was to identify in the MSA
the positions subjected to speciﬁc evolutionary pressure in the subfamily of
MsbA-like bacterial lipid export ABC transporters. To obtain positions
which are more speciﬁc to the A1 subgroup, conservation scores for each
amino acid position in MSA1 were computed using rate4site and compared
FIGURE 1 (A) General presentation of the open-state MsbA structure
reconstruction, only considering its transmembrane domain. The ribbons are
colored from blue to green from the N- to C-terminus of the M1monomer and
fromgreen to red from theN- toC-terminusof theM2monomer. (B) Schematic
key phospholipids organization on the intracellular side of the protein.
TABLE 2 Equilibration procedure
Step Length Type* Frozen groups Restrained groups
1 1000 steps SD Protein, lipids –
2 500 ps NVT Protein, lipids –
3 1000 steps SD Protein –
4 500 ps NVT Protein –
5 1000 steps SD Protein backbone –
6 500 ps NVT Protein backbone –
7 500 ps NPT – Protein backbone
*SD refers to steepest descents energy minimization. NVT refers to
simulations in the NVT ensemble at 300 K using Berendsen algorithm and
a coupling constant tT ¼ 0.1 ps. NPT refers to simulations in the NPT
ensemble at 300 K, and 1 bar using a coupling constant tP ¼ 2 ps and a
compressibility of 4.5 3 105 bar1 in all box directions.
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with those considering MSA2. The rate4site program assigns a conﬁdence
interval to each of the inferred evolutionary conservation score. For site
speciﬁc comparison, nonoverlapping 95% conﬁdence intervals (45) were
used to indicate signiﬁcant rate variations between both the MSA1 and the
MSA2. One position was deﬁned as speciﬁcally conserved in close
homologs of MsbA-like proteins if the estimated conﬁdence intervals
between MSA1 and MSA2 did not overlap (the rate variation is deﬁned as
positive if the site is more conserved in the truncatedMSA1). Only sites with
a positive rate variation and a negative upper conﬁdence limit considering
MSA1 are deﬁned as speciﬁcally conserved in the set of close homologous
sequences (negative score indicates strong conservation).
RESULTS
To investigate the MsbA dimer stability as well as the lipid
organization around such an assembly, a 50-ns simulation
has been performed. Since lipid organization around the
MsbA dimer cannot be predicted a priori, the simulation was
started from an out of equilibrium structure in which the
lipids close to the protein cavity entrance do not possess the
equilibrium structure. The simulation has therefore been split
up into two parts. In the ﬁrst part (0–16 ns), the protein
backbone was harmonically restrained, allowing lipids to
organize themselves around the MsbA dimer and avoiding
protein denaturation early in the simulation owing to inap-
propriate environment. In the second part of the simulation,
the restraints were removed. The entire simulation provides
information about the lipid-protein interactions, and the sec-
ond part reports on the stability of these interactions and of
the protein. Finally, conservation analysis enables us to ex-
amine those results in light of phylogenetic data.
A second ;20-ns simulation was performed in which the
MsbA cavity was ﬁlled with POPE lipids (data not shown).
The lipids quickly dived inside the cavity (;1 ns) and
remained trapped for the remaining of the simulation.
Calculation of the electrostatic potential of the MsbA inner
cavity (data not presented) revealed its polar nature. It hence
leads us to the conclusion that the cavity was more likely to
interact with solvent in its steady state. The arrangement
obtained might be an intermediate state or a local energy
minimum. In both cases, the simulation time was not suf-
ﬁcient to observe a signiﬁcant rearrangement of the system.
The remainder of this work therefore only presents results
referring to simulations where the protein cavity was ﬁlled
with solvent.
Lipid organization around the protein
Before restraints on the lipid phosphorus along the z axis are
removed, the bilayer is ﬂat and the MsbA hinge region is in
contact with both the cytosol region and the hydrocarbon
chains of lipids in the vicinity. The hinge region corresponds
to the interface of the two monomers that is located in the
hydrophobic region of the membrane and in contact with the
solvent. This region is deﬁned by helix 2 of the ﬁrst mono-
mer and helix 5 of the second on one side and reciprocally on
the other side (Fig. 1). This is a nonphysical arrangement
since it involves contact between hydrophobic chains and
polar residues of the protein as well as with the solvent (Fig.
2 A). During the last 1.5 ns of equilibration, where restraints
on the POPE lipid phosphorus atoms are removed, a mi-
gration of the phospholipids headgroups toward the hinge
region of MsbA can be observed (Fig. 2 B). This arrange-
ment of POPE lipids around the protein early in the sim-
ulation before proper production is started balances out
unfavorable interactions between protein, lipids, and solvent.
The resulting organization, which can be described as a
semipore-like structure, ensures that no hydrophobic groups
are in contact with hydrophilic groups. The curvature of the
cytosolic monolayer is indeed modiﬁed in the proximity of
the protein hinge region. However, the membrane perturba-
tion is only very local, not concerning the exoplasmic leaﬂet
FIGURE 2 Lipid migration in the vicinity of the MsbA hinge region. Structure of the assembly at the beginning of the equilibration (A) (t¼ 1.5 ns) and at
the end of the equilibration (B) (t ¼ 0 ns). Protein is represented in blue, phospholipids chains are represented in gray lines, and headgroup atoms in spheres.
For purpose of clarity, solvent and counterions are omitted. The extracellular region is located above the protein and the intracellular region below. The black
frame highlights the very local perturbation of the cytosolic leaﬂet surrounding the protein.
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and not propagated to long distances: outside a perimeter of
10 A˚ from the hinge region of MsbA, the bilayer is no longer
perturbed and lipid headgroups regain their normal heights
similar to that of lipids in the bulk of the membrane (Fig. 3).
Lipid-protein interaction
Two key phospholipids play an important role in the stability
of the interface between the hinge region of MsbA and the
membrane, POPE79 and POPE217. These phospholipids
interact with the protein and remain in the hinge region
during the integrality of the simulation. Quantifying lipid-
protein interactions, as deﬁned by atoms within 0.35 nm of
each other, reveals that these phospholipids interact exclu-
sively with helices 2 and 5 (see Fig. 1 B for a schematic
representation). Indeed, interactions with these helices make
up the integrality of the interactions with the protein. Both
phospholipids have a similar number of interactions with
helix 5, which stabilizes between 15 and 20 (Fig. 4). Most of
these contacts are van der Waals contacts since helix 5
mostly contains hydrophobic and aromatic residues. On the
other hand, POPE79 and POPE217 have a different behavior
with respect to helix 2 (Fig. 4). Whereas POPE79 has a limited
number of interactions with this helix (,2), POPE217 makes
most of its interactions with the protein with helix 2 (;20–30
interactions). This suggests different conformations for these
two POPE molecules.
The total number of protein-lipid interactions is steadily
increasing during the unrestrained part of the simulation.
There are ;1300 interactions after 16 ns and ;1500
interactions at the end of the simulation. Even though total
simulation time reached 50 ns, the protein is still further
stabilized by the membrane at the end of the study, and a
ﬁnal steady state is not completely reached.
As a likely consequence for the fact that their locations
and conformations are directly dependent upon the initial
conformation, and indeed upon the process used to generate
the protein-membrane complex, these two phospholipids
adopt two different conformations. Whereas lipid POPE79
has its two hydrophobic chains outside of the protein cavity,
lipid POPE217 has one chain half inside the cavity (SN2)
and the other outside (SN1).
The examination of the average minimum distance of
these two phospholipids with residues making helices 2 and
5 reveals the importance of several residues (Fig. 5). In helix
2, arginine Arg-78 and threonine Thr-81 are particularly
important for the protein-lipid interface structure (see Fig.
1 A). Both residues are on average ,0.2 nm away from
POPE217, whereas with POPE79 only residue Thr-81 is
at close distance (0.25 nm on average), testifying to the
presence of two distinct conformations. In helix 5, most
interactions are van der Waals contacts with hydrophobic
residues Ile-258, Ser-260, Ala-262, and Phe-265 for POPE79
and Ile-258, Ala-262, and Phe-265 for POPE217.
The number of H-bonds (data not presented) also reveals
two distinct behaviors. The total number of H-bonds sta-
bilizes during the constrained part of the simulation and
FIGURE 3 Average height of the phospholipid headgroup atoms in the
intracellular layer over the 0–16-ns time range, in nanometers. Headgroup
atoms considered in the calculations included those from the phosphatidyl
ethanolamine group as well as those from the glycerol part. The grid size was
2.0 A˚. The color scale is arbitrary.
FIGURE 4 (A) Overall number of lipid-protein interactions (cutoff
0.35 nm). (B) Number of interactions between lipid POPE79 and helix 2 of
monomer 2 (black line) and helix 5 of monomer 1 (gray line). (C) Number of
interactions between lipid POPE217 and helix 2 of monomer 1 (black line)
and helix 5 of monomer 2 (gray line). (D) Overall number of interactions
betweenprotein and lipid POPE79 (black line) and lipid POPE217 (gray line).
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increases after constraints are removed to stabilize at around
80 H-bonds at the end of the simulation. During the unre-
strained part of the simulation, local ﬂuctuations of the
protein enable new H-bonds to be created, further stabilizing
the protein inside the membrane. The two individualized
phospholipids have distinct behavior toward H-bonding.
POPE217 interacts more with the protein than POPE79
and ;4 and ;1 H-bonds during the unrestrained part of the
simulation, respectively. POPE79 has between one and two
H-Bonds with helix 5 and occasionally one with helix 2. The
other phospholipid, POPE217, has a greater number of
H-bonds: up to four with helix 5 during the unrestrained part
of the simulation. Interactions with helix 2 are more limited,
between 1 and 2 H-bonds.
In agreement with these analyses, visual examination of
these phospholipids (Fig. 6) shows the presence of one
FIGURE 5 Average minimum distance of characteristic lipids POPE79 and POPE217 with each residue of the helices making the interface between the
two protein monomers (helices 2 and 5). Proﬁles are calculated in 500-ps windows and averaged over all windows. (A) Minimum distance between lipid
POPE79 and residues of helix 2 of monomer 2, (B) minimum distance between lipid POPE79 and residues of helix 5 of monomer 1, (C) minimum distance
between lipid POPE217 and residues of helix 2 of monomer 1, and (D) minimum distance between lipid POPE217 and residues of helix 5 of monomer 2.
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H-bond between POPE79 and threonine Thr-81. The other
phospholipid has two H-bonds with arginine Arg-78 and one
H-bond with threonine Thr-81.
Lateral motion of lipids
In terms of short scale lateral diffusion, two classes of lipids
can be distinguished: bound and free lipids (30). In our
analysis, bound lipids were deﬁned as those that had their
phosphorus atom within 5 A˚ of the protein at the beginning
of the simulation, whereas free lipids are deﬁned as those not
having their phosphorus atom within 5 A˚ of the protein. The
selection was updated every 500 ps. To investigate the in-
ﬂuence harmonic restraints might have on the lipid diffusion
behavior, lateral diffusion coefﬁcients have also been cal-
culated for time range representative of the restrained and
unrestrained part of the simulation, respectively, 1–15 ns and
20–50 ns. Characteristic lipids POPE79 and POPE217 have
also been characterized. Values for short scale lateral diffu-
sion coefﬁcients are summarized in Table 3, where POPE44
is representative of a bulk lipid.
As frequently seen, free lipids have a larger diffusion co-
efﬁcient than bound phospholipids but of the same order of
magnitude. In contrast, POPE79 and POPE217 have smaller
diffusion coefﬁcients, as testiﬁed by the values obtained for a
lipid located in the bulk, POPE44. The POPE79 diffusion
coefﬁcient is smaller than that of POPE217. This can be
linked to the different conformations the two phospholipids
are adopting, since POPE79 has its two hydrophobic chains
outside of the protein cavity whereas POPE 217 has one
chain inside the cavity and one chain outside. Lipids
transported by MsbA are supposedly recruited inside the
membrane before being ﬂipped and expelled in the extra-
cellular side membrane as suggested by Reyes and Chang
(17) in the case of lipopolysaccharide (LPS). In our case,
POPE217 might be in an intermediate state that would
explain a signiﬁcantly higher diffusion coefﬁcient than
POPE79. In light of these considerations, it is interesting to
study the inﬂuence of restraints on these diffusion coefﬁ-
cients. Restraints have little effect on diffusion coefﬁcients of
the free, the bound, and the entire set of phospholipids. They
have nonetheless a signiﬁcant inﬂuence on the key phos-
pholipids POPE79 and POPE217. Once restraints are re-
moved, POPE217 diffusion is about two times larger, an
observation consistent with the hypothesis of a transition
state in which signiﬁcant protein conformational change is
required to allow the lipid to be transported. The POPE79
diffusion coefﬁcient is, on the other hand, reduced by a factor
of 2. Local protein movement observed in the unrestrained
part of the simulation might allow this phospholipid to reach
a stable state by enabling it to reach an energy minimum.
These observations can be corroborated by the examinations
of root mean square deviations (RMSDs) (see Fig. 8 B).
Helix 5 of monomer 1, which is in contact with phospholipid
POPE217, is prone to more ﬂuctuations (ﬁnal Ca RMSD
0.361 nm) than its counterpart of monomer 2 interacting with
the other phospholipid (ﬁnal Ca RMSD 0.316 nm). Helices
2 have similar RMSDs in both monomers.
Protein stability
Protein stability can be characterized by examining the
RMSD of the protein structure as a function of time. RMSDs
for the entire protein together with monomer 1 and 2 are
presented in Fig. 7. The RMSD of the entire protein con-
tinuously increases during the restrained part of the simu-
lation to reach 0.25 nm after 16 ns. After removal of the
restraints, RMSD keeps on rising but stabilizes at 0.51 nm
after 25 ns without any further signiﬁcant drift. When plot-
ting the contributions of the two monomers separately, it
appears that the contribution from monomer 2 is larger than
that of monomer 1, with ﬁnal values of, respectively, 0.51 and
0.47 nm. These values, although large, are of the same order
of magnitude as the one observed by Campbell et al. in their
in silico study of MsbA (19). These numbers have to be
related to the resolution of the crystal structure used (0.45 nm)
FIGURE 6 Snapshot of key protein-lipid interactions seen from the
cavity. The extracellular side is located on the bottom and the intracellular
side above. The bottom ribbon representation of the MsbA dimer indicates
the orientation of the protein. The ribbons are colored from blue to green
from the N- to C-terminus of the M1 monomer and from green to red from
the N- to C-terminus of the M2 monomer. In both diagrams the protein is
shown in ‘‘cartoon’’ format (in green). Selected side chains and lipids are
shown in ‘‘sticks’’ format, with nitrogen and oxygen atoms colored blue and
red, respectively. (A) Threonine (Thr-81) residue interacting with phospho-
lipid POPE79. The threonine hydroxyl group is H-bonded with the POPE
SN2 carbonyl group. (B) Threonine (Thr-81) and arginine (Arg-78) residues
interacting with phospholipid POPE217. The threonine hydroxyl group is
H-bonded with the POPE SN1 carbonyl group. The arginine amine group is
H-bonded with the POPE SN2 carbonyl and ester group.
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and to the fact that it only contains a Ca trace. Furthermore,
our study only considers the transmembrane domain of the
protein: missing intracellular loops likely have a direct inﬂu-
ence on the stability of the assembly.
The secondary structure reports on the protein stability over
the course of the simulation (see Fig. 1 in Supplementary
Data). Signiﬁcant loss of helicity is observed for helix 3 in
both monomers, helix 4 in monomer 1, and helix 5 in both
monomers.Most of the loss of secondary structure happens on
the extracellular side of the protein. This observation can be
explained by the fact that intracellular loops joining helices 4
to 5 and helices 2 to 3 have been omitted for computational
reasons. Consequently, amino acids located at the cut and in
the vicinity of themembrane polar headgroups tend to interact
with the latter, causing some helices to slide toward the
intracellular side. Helices 3 and 4 are particularly exposed to
the membrane headgroups, which could explain the loss of
helicity observed on the extracellular side. The loss of helicity
observed might be related to its interaction with the elbow
helix. Interestingly, the elbow helix, whichwasmodel built, is
conserved in the integrality of the simulation (especially in
monomer 2). This feature was not observed in the study of
Campbell et al. (19), which reveals the importance of the
membrane choice for the protein stability.
Motions in the protein have been further characterized by
examining tilt angles with respect to the membrane normal
and the RMSDs of each helix relative to itself as a function of
time (Fig. 8). Helices 2, 3, 4, and 6 show similar tilt angle
ﬂuctuations in both monomers with a ﬁnal drift of ;5, a
value reﬂecting standard oscillations that might be observed
in MD simulations exceeding tens of nanoseconds. There is
a signiﬁcant difference in the ﬁnal tilt angles of helix 5 in
monomers 1 and 2. Whereas the helix in monomer 2, which
is in contact with phospholipid POPE79 does not show any
signiﬁcant ﬁnal drift, helix 5 of monomer 1 shows a ﬁnal
drift of nearly 10. This helix is in contact with phospholipid
POPE217, which undergoes signiﬁcant conformational change
as noted above. We might therefore think that the observed
tilt angle drift is part of the mechanism allowing phospho-
lipid POPE217 migration toward the protein cavity and not
just standard ﬂuctuation. Concerning helix 1, there is a sig-
niﬁcant difference between the two monomers. The tilt angle
is prone to more ﬂuctuations in the ﬁrst monomer; the
question of whether this observation is signiﬁcant remains to
be elucidated. Intrahelix RMSDs are similar for both mono-
mers except for helices 4 and 5. For the latter, the drift is
more important in the ﬁrst monomer, a logical observation
considering the fact that this helix interacts with phospho-
lipid POPE217, which undergoes signiﬁcant conformational
change. Helices 1, 2, and 6 are quite stable considering the
overall protein stability, with ﬁnal drifts of the order of
0.3 nm or less. The remaining helices show larger structural
ﬂuctuations with ﬁnal drifts of the order of 0.4 nm.
Dimer dynamic behavior
Time evolution of the two monomers principal axes of inertia
has been investigated. In Fig. 9 we report the angles made by
the two monomers with the bilayer normal (z axis), together
with the angle between the two monomers’ axes of inertia.
Both monomers are relatively stable. Monomers are initially
oriented with an angle of 35 with respect to the bilayer
normal; after restraints are removed, these angles oscillate
with an amplitude of ,10 to reach ﬁnal values of 37 and
TABLE 3 POPE lipids short scale lateral diffusion coefﬁcients (3 105 cm2 s1)
Time range (ns) D*§ , 5 A˚ Dyz . 5 A˚ Overallz POPE79§ POPE217§ POPE44§
0–50 0.0217
(60.0080)
0.0334
(60.0051)
0.0323
(60.0048)
0.0034
(60.0019)
0.0082
(60.0090)
0.0104
(60.0098)
0–15 0.0215
(60.0086)
0.0340
(60.0052)
0.0334
(60.0048)
0.0070
(60.0030)
0.0048
(60.0044)
0.0094
(60.0051)
20–50 0.0227
(60.0075)
0.0334
(60.0050)
0.0327
(60.0047)
0.0033
(60.0020)
0.0114
(60.0107)
0.0134
(60.0125)
*Lipids for which a phosphorus atom is located within 5 A˚ of the protein at the beginning of the simulation, updated every 500 ps.
yLipids for which a phosphorus atom is located above 5 A˚ away from the protein at the beginning of the simulation, updated every 500 ps.
zDiffusion coefﬁcients calculated in 500-ps frames.
§Diffusion coefﬁcients calculated in 5-ns frames.
FIGURE 7 Time evolution of Ca RMSDs for protein (black line),
monomer 1 (black dotted line), and monomer 2 (gray line). Intramonomer
RMSDs are calculated by ﬁtting each monomer on itself and measuring
RMSDs relative to the ﬁt over time.
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29, respectively, for monomers 1 and 2. Considering the
length of the simulation, these drifts testify to the stability of
the assembly. Observation of the angle between the two
monomers’ principal axes of inertia reveals a slight closing
of the chamber. The angle has an initial value of 70,
which decreases during the simulation to reach a ﬁnal value
of 63. Our protein model did not include the nucleotide
binding domains, leaving helices of the intracellular domain
free to interact with the membrane surface. These interac-
tions affect the stability of the assembly and can partly
explain the closing of the chamber. Indeed, the concerned
amino acids tend to bend the helices to favor interactions
with the membrane headgroups. These interactions do not
affect the assembly stability on the timescale of this study
(ﬁnal drift of 7) but might have more signiﬁcant effects if
longer timescales were considered.
The dimer stability has been further examined by inves-
tigating the time evolution of the number of H-bonds be-
tween the two monomers (Fig. 10). Since H-bonds between
atoms can form and disappear quite quickly, the total number
of H-bonds is subject to signiﬁcant ﬂuctuations. Hence, only
the general trend of the curve is discussed here. The initial
number of polar contacts is limited, with one to two H-bonds
between the two monomers. This number continuously
increases during the restrained part of the simulation (up to
16 ns) to reach a value of ;6 H-bonds. During the unre-
strained part of the simulation (16 ns and beyond), the
number of H-bonds initially decreases to about four inter-
actions and ﬁnally ‘‘stabilizes’’ at about six interactions from
34 ns to the end of the simulation. This plateau testiﬁes to the
stability of the dimer interface.
The examination of polar contacts at different times re-
veals that most H-bonds are between extracellular domain
1 (ECD1) of one monomer and extracellular domain 3 (ECD3)
of the other monomer, and reciprocally. Typical H-bonds are
illustrated in Fig. 11. ECD1 of the ﬁrst monomer, which is
the loop joining helices 1 and 2, is drawn in blue; and ECD3
of monomer 2, the loop joining helices 5 and 6, is drawn in
red. On this snapshot, amino acids Leu-52, Asp-53, Phe-56,
Gly-57, Lys-58, and Arg-61 of ECD1 are H-bonded to
amino acids Ser-274, Val-275, and Asp-276 of ECD3.
Among notable interactions, the H-bond between the
carboxyl group of Asp-276’s side chain and the NH group
ofArg-61’s side chain aswell aswith theNHgroup of Lys-58’s
FIGURE 8 Time evolution of helices tilt with respect to the bilayer normal (A) and intrahelix Ca RMSDs (B) for monomer 1 (black line) and monomer
2 (gray line). Intrahelix RMSDs are calculated by ﬁtting each helix on itself and measuring RMSDs relative to the ﬁt over time.
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backbone can be highlighted. H-bonds between Asp-53, Ser-
274, and Val-275’s backbone CO groups and Val-275, Phe-
56, and Gly-57’s backbone NH groups, respectively,
together with H-bonds between Leu-52’s backbone CO
group and the Ser-274 hydroxyl group are relatively stable
and can be observed during most of the second part of the
simulation. These observations reveal the existence of a
dimer interface which is stabilized by the appearance of
numerous H-bonds during the course of the simulation and
noticeably interactions involving backbone atoms.
Conservation analysis
We ﬁrst analyzed the projection at the protein surface of the
evolutionary conservation based on the MSA of 49 MsbA-
like ABC transporters. Fig. 12 A shows that conserved
positions (colored red) can be found in different regions of
the protein. The regions with the highest concentration of
conserved positions are located inside the dimer cavity at the
level of the cytosolic lipid interface and at the hinge between
both monomers (shown in Fig. 12 A as hinge M1 and hinge
M2 for monomers 1 and 2, respectively). The residues
located at the membrane interface interacting with the lipid
headgroups also appear relatively conserved, probably to
ensure a proper positioning of the protein in the bilayer. In
contrast, the external surface of the protein pointing toward
the hydrophobic lipid environment contains more variable
positions. Indeed, as long as the hydrophobic character of the
residues is kept at the lipid-exposed surface, the structural
integrity and function of the protein is likely to be main-
tained. The structure of the MsbA analyzed in this simulation
only contains the transmembrane domain. Hence conserva-
tion data shown here only concern this region of the MsbA
protein. It is interesting to note that in the entire structure
the region containing the ICD region is also conserved to
a similar extent as that of the internal cavity. This conserva-
tion probably demonstrates the importance of these regions
in transmitting a proper signal transduction between the
domains involved in the hydrolysis of the ATP and the
transmembrane domain involved in the physical transport of
substrates.
To further investigate the evolutionary constraints existing
in the MsbA protein family, we decided to discriminate
between two types of evolutionary pressures: i), those
involved in the general transport mechanism of compounds
through the membrane likely to be common to the entire
ABC transporter superfamily, and ii), the conservation
events that speciﬁcally occurred in the MsbA close homo-
logs for reasons such as the speciﬁcity of the substrate
FIGURE 9 Time evolution of the principal axis of inertia of monomers
1 and 2. Angles of the principal axis of inertia of monomers 1 and 2 with
the bilayer normal are reported together with the angle between the
two monomers’ principal axes of inertia.
FIGURE 10 Time evolution of the number of H-bonds between the
two monomers. The cutoffs used to deﬁne H-bonds are 0.25 nm for the
hydrogen-acceptor distance and 60 for the donor-hydrogen-acceptor angle.
FIGURE 11 Snapshot of polar contacts between the two monomers at
t¼ 25 ns. The protein is seen from the extracellular side. The protein is shown
in ‘‘cartoon’’ format; selected side chains are shown in ‘‘sticks’’ format with
nitrogen and oxygen atom colored blue and red, respectively. Helices 1 and
2 of monomer 1 are colored in dark and light blue, respectively, and helices
5 and 6 of monomer 2 are colored in orange and red, respectively. Illustrated
H-bonds are those present between extracellular domains 1 and 3.
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recognition. In that scope we further aligned 47 sequences of
ABC transporters more distantly related to MsbA in the
evolution. The clustering between the close and remote
homologs was based on a rigorous phylogenetic tree analysis
of the entire set of 96 sequences. We then analyzed among
the conserved positions of MsbA homologs those positions
signiﬁcantly more conserved in the set of close homologs
of MsbA than in the set of remote ones. This protocol
corresponds to a differential conservation analysis based on
the comparison of evolutionary rates and of their associated
conﬁdence intervals (see Methods). Interestingly, using a
stringent conﬁdence interval (probability above 95%) only
two positions stand out, Arg-78 and Trp-165 (Fig. 12 B).
Residue Arg-78 stands at the dimer hinge region, whereas
residue Trp-165 is located in a loop pointing out toward the
extracellular medium. Decreasing the conﬁdence interval to
90%, three other positions are found to exhibit a differential
conservation effect: Gln-134, Ala-142, and Ser-186 (see
Figs. 2 and 3 in Supplementary Material). These residues are
located in helices 3 and 4 close to the inner membrane
interface. Although at this stage we cannot further interpret
these evolutionary pressures, the conservation pattern sug-
gests that these residues may also play a speciﬁc and im-
portant role inMsbA close homologs. Among the ﬁve positions
pinpointed by the differential conservation protocol, Arg-78
remains the most conserved position in E. coliMsbA’s close
homologs. Arg-78 is precisely the residue found interacting
with the two key lipids (POPE79 and POPE217 in our
simulation) and stabilizing the semipore-like structure.
DISCUSSION
MsbA is a bacterial ABC transporter ﬁrst recognized to
export lipid A, a toxic metabolic intermediate involved in the
biosynthesis of the outer membrane, and now reported to
also handle various lipids, LPSs, and even cytotoxic drugs.
As a lipid transporter, it is of interest to investigate the
relationships between lipids and this protein, both from a
general view of membrane biophysics and from the speciﬁc
perspective of its molecular mechanism of functioning. As
a multispeciﬁc active exporter of amphiphilic compounds,
analyzing its molecular properties is highly desirable to gain
some useful knowledge in the molecular enzymology of the
mammalian multidrug transporter, P-gp, remarkable for its
close structural and functional homologies, which would be
valuable in various pharmacological applications. In this
context, the evidencing by MD simulations of speciﬁc
interaction of two phospholipid molecules at the hinge of
MsbA dimer structure, in parallel with a very local invagi-
nation of the cytosolic leaﬂet of the membrane surrounding
the protein as a consequence of its open-state conformation,
can be considered a signiﬁcant shedding of light on this
model of ABC transporter. Moreover, these observations
might be of great interest to suggest site-directed mutagen-
esis experiments.
Assessment of the model quality
MD is an adequate tool for analyzing molecular mechanisms
determining protein-lipid interactions. However, the quality
of the protein structure modeled is of prime importance for
the reliability of the data generated. Actually, since we
started from a rather moderate resolution crystal structure,
we have chosen to take into account only the transmembrane
domain of the protein, without considering the nucleotide
binding domains and the other fragments clearly outside the
membrane, because they would imply constraints that are too
speculative when compared to their expected low repercussion
FIGURE 12 Conservation analysis calculated from
the MSA of MsbA proteins and mapped on the surface
of the dimer. The top ribbon representation of the
MsbA dimer indicates the orientation of the corre-
sponding surface representations shown below in
panels A and B. The ribbons are colored from blue to
green from the N- to C-terminus of the M1 monomer
and from green to red from the N- to C-terminus of the
M2 monomer. (A) The surface of monomer M2 is
colored with respect to the conservation scores. Most
to least conserved positions are colored from red to
white, respectively, yellow corresponding to the aver-
age conservation score (left, middle, and right panels
show the interior, the lipid-exposed, and the hinge
regions of the dimer, respectively). (B) Positions that
are speciﬁcally and signiﬁcantly conserved in the
MsbA close homologs family but not in the more
general LPS ABC transporters family are colored in
red at the surface of M2 monomer (left and right panels
show the interior and the lipid-exposed regions,
respectively).
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on transmembrane domain dynamics. This has been vali-
dated a posteriori as shown by the reasonable stability which
is obtained for the protein. In addition, this may be consistent
with a report on the related protein P-gp according to which
the transmembrane domain alone is sufﬁcient for trafﬁcking
to cell surface and drug recognition (46). Missing intracel-
lular domains make difﬁcult a strong assumption of the
model quality, and this point will be obviously further tested
only after modeling the whole protein. Nevertheless, a
PROCHECK (47) analysis performed on the initial structure
revealed that all protein-health characteristics were within
the acceptable range.
Structural stability of the protein
Even though intrahelical RMSDs denote important structural
drifts for some transmembrane segments, the dimer structure
is relatively stable. Previous studies performed using an
octane slab (19) showed large structural drift of the trans-
membrane domains over just 1 ns. Our study shows a sig-
niﬁcant drift that stabilizes at 0.5 nm after 25 ns and remains
constant until the end of the simulation. This highlights the
critical role played by the nature of the membrane in the
stability of the assembly. The structure used in this study was
closely based upon the crystallographic MsbA Ca coordi-
nates (PDB code, 1JSQ). The rather poor resolution of this
structure partly explains the ﬂuctuations observed in our
simulation. The signiﬁcant rearrangement of transmembrane
helices that can be observed is not typical in membrane
protein simulations. MsbA is a lipid transporter that suppos-
edly undergoes signiﬁcant transmembrane domain rearrange-
ment during the transport cycle. As such, the transmembrane
domains must consequently be very ﬂexible, which could
explain the structural drifts observed in this study. Anyway,
this does not preclude the conclusions shown by the simu-
lations about lipid dynamics in the protein environment.
Implication for lipid transport
The presented simulations show that the open-state MsbA
structure can be inserted into a lipid membrane and that this
structure may be physiologically viable. This (resting)
conformation is in agreement with recent data obtained
using electron paramagnetic resonance and chemical cross-
linking techniques (48). Thanks to the dynamic vision they
allow, the molecular simulations also give invaluable
insights into the transport mechanism that might be adopted
by MsbA to translocate lipids.
MsbA transports lipid A and also phospholipids and LPSs
(7). Furthermore, it has been recently shown experimentally
that MsbA is responsible for the export of lipid A by
mediating its transbilayer translocation (i.e., it displays a
‘‘ﬂip-ﬂoppase activity’’) (49). From the crystal structure
obtained for S. typhimurium MsbA, a transport mechanism
has been suggested by Reyes and Chang (17) from the
sequestration of the polar sugar headgroup of LPS. The ﬁrst
two steps involve i), initial binding to the elbow helix of the
apo structure, and ii), lipid headgroup insertion in the cham-
ber of the apo structure. The last two steps involve trans-
porter conformational change related to ATP binding and
hydrolysis involving lipid headgroup ﬂip while lipid chains
are dragged through the lipid bilayer. In our simulation,
analysis of protein-lipid interactions reveals the occurrence
of two distinct conformations for phospholipids POPE79 and
POPE217. These two singularized phospholipid molecules
are actually the result of statistical sampling yielded by MD
simulation. These two conformations might be in agreement
with the transport mechanism suggested by Reyes and
Chang in the sense that they show that the alkyl chains of
these lipid molecules can adopt different conformations
when interacting with this protein environment. This obser-
vation is also in good agreement with the differential con-
servation analysis that pinpointed the residue Arg-78 as one
of the residues highly conserved in close homologs of MsbA
although more variable in more distantly related organisms.
All along the simulation, this residue is found interacting
with the heads of the phospholipids POPE79 and POPE217
and stabilizing the semipore structure. Although lipid A was
not included in the simulation, the evolutionary pressure
found at position 78 may well reﬂect the functional spec-
iﬁcity of the MsbA for the binding of lipid A.
Otherwise, we observed local and partial invagination in
the cytosolic leaﬂet of lipid headgroups in contact with the
protein, this being a direct consequence of the optimal ﬁlling
of the periproteic space taking into account geometric con-
straint induced by the open state. This very local membrane
structure perturbation might be the preliminary step of the
transport mechanism. This would eventually imply translo-
cation of the polar headgroup, coupled with energy-giving
ATP hydrolysis, within the chamber of the observed semipore-
like assembly. Indeed, it can be assumed that the subsequent
energy-requiring translocation step will happen on a far
larger timescale and will be accompanied by a signiﬁcant re-
arrangement of the protein.
In addition, if we consider, in agreement with Chang’s
suggestion (16), as a fair possibility that MsbA alternates
during its enzymatic cycle between open and closed states, it
appears that the most altered part of the protein during such
a transconformation is the hinge deﬁned by the dimeric
association. The fact that the hinge between both monomers
is one of the most conserved regions in the transmembrane
domain also supports the functional importance of this
region in the transport process. It is then relevant, and even
remarkable, that two phospholipids have been individualized
on the hinge regions of the protein, located in the contact re-
gion of helices 2 and 5. These phospholipids establish
speciﬁc interactions with the protein, when compared to
other phospholipids in the bulk or in the ring surrounding the
protein. They adopt two distinct conformations, resulting
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from the initial setup of the simulation. Interestingly, their
location is similar to the one suggested for initial LPS bind-
ing in the structure of S. typhimurimMsbA (17), proposed at
the level of the hinge of the dimer, involving elbow and helix
1 but also helices 2 and 5 due to the size of the ligand. This
constitutes a clear evocation of possible transport site, which
would mainly involve six amino acids in each side of the
hinge and could be a general characteristic of substrate
transport by MsbA. Actually, this would be in full agreement
with the fact that the drugs handled byMsbA are amphiphilic
and likely come to interact with the protein via the mem-
brane phase after partitioning into the lipids, as described for
P-gp.
Connection with P-gp functioning
The mammal multidrug transporter P-gp is responsible for
the MDR of some tumor cells against cytotoxic drugs used in
anticancer chemotherapy, leading to treatment failures. P-gp
presents enough sequence homology with MsbA to raise an
interest in analyzing MD data to possibly shed light on its
transport function. In particular, P-gp is now described as
being rather a translocase, and more precisely a ﬂoppase,
realizing the active transfer of its hydrophobic substrates,
lipids, or drugs, from the cytosolic to the exoplasmic leaﬂet.
As an ABC protein with a tandem structure, it looks like a
possible MsbA dimer. Such a ‘‘reminiscence’’ of a dimeric
structure is supported by data showing that the coexpression
of the two halves of the protein is able to exhibit a drug-
stimulated ATPase activity, a fair indication of a full func-
tionality, whereas each separated half is only capable of a
basal ATP hydrolysis (50). In the same line, it has been
shown by molecular biology techniques that a good ﬂexi-
bility of the linker between the N- and C-terminus is required
for P-gp activity (51). From a structural point of view, the
low resolution image obtained by tridimensional reconstruc-
tion shows an inner chamber with a possible opening/
communicating to the near lipid phase (52). This protein
structure displays under the action of ATP hydrolysis a large
amplitude transconformation (53) involving tertiary structure
changes evidenced by various spectroscopic techniques (54–
56). Furthermore, projection data from two-dimensional
crystals of P-gp are consistent with the MsbA transmem-
brane domain structure (57), even if more recent structure
reﬁnements have shown that P-gp does not have a strictly
symmetric transmembrane domain (58). As a whole, since
the molecular mechanism of P-gp-mediated drug transport is
currently very poorly understood, available data make MsbA
a fair structural and functional model for P-gp in the frame of
a ﬁrst approach.
The data generated by molecular simulation of the in-
teractions between MsbA and surrounding lipids have pin-
pointed few amino acids in the hinge region of the protein,
involving helices 2 and 5 from each of the two MsbA
monomers, for being able to speciﬁcally interact with par-
ticular lipid molecules. This is strikingly consistent with
experimental data coming from cross-linking assays of the
helix-helix neighborhood in P-gp, evidencing a close prox-
imity between helices 2 and 11 as well as between helices 5
and 8 (59). In addition, helix 11 in P-gp has often been
involved by directed point mutagenesis experiments in the
speciﬁcity of drug recognition (60,61). Also, different photo-
labeling experiments indicated helices 4-5-6, 7-8, and 11-12
as targets for drug binding (62–64). Furthermore, it has been
reported that among the 12 helices in P-gp, 7 (1-2-3-5-6-8-
11) are rich in aromatic residues conserved among the
various isoforms of P-gp, 4 of them (3-5-8-11) being suited
for interacting with rhodamine 123, a typical polycyclic drug
substrate, even if this is the result of a rather crude molecular
modeling process considering each of the P-gp helices sep-
arately (65). As a whole, helices 5, 8, and 11 in P-gp thus
appears to be consistently involved in the transported
substrate recognition. In addition, among the six amino
acids of MsbA speciﬁcally interacting with POPE lipids,
three of them are conserved in the aligned P-gp sequence in
each of its half-tandem: Ser-260, Ala-262, and Phe-265
respectively conserved in positions 309-311-314 and 952-
954-957. According to available mutagenesis data (60),
these residues are located close to some of the various amino
acids involved in drug recognition by P-gp.
Finally, the molecular characteristics obtained here for
MsbA interaction with membrane lipids, and that can be
favorably compared with what is known for P-gp, could also
be considered for the other ABC transporters from the B
subfamily, which have the closest homology with MsbA. In
particular, ABC B4 (also called MDR3) is known as a
phosphatidylcholine translocase, mainly expressed in biliary
canalicule where it participates to bile secretion (3), and it is
conceivable that such a phospholipid transporter shares with
MsbA (and P-gp) some similarities at the molecular level for
transport mechanism. Also, ABC B2 and B3 (also known as
TAP1/2) constitute as a dimer a transporter of hydrophobic
peptides, formed by antigenic restriction and loaded into
endoplasmic reticulum of macrophages (66), which have
ﬂexible structures and could thus be handled in a similar
manner to phospholipids. Indeed, in this study, we showed
that the coupling between simulation data and phylogenetic
analyses could powerfully highlight residues likely to play
a role in the transport of a speciﬁc class of substrates. The
protocol developed here may be applied in the future to other
classes of ABC transporters provided enough sequences can
be aligned together with the corresponding knowledge on
their transport speciﬁcities.
As a conclusion, based on the structure of the bacterial
ABC transporter MsbA, molecular dynamic simulation of a
large atomic system comprising a membrane protein inserted
in its lipid membrane environment has allowed us to evi-
dence the functional importance of the hinge region of the
dimeric protein and the destabilization of the cytosolic
leaﬂet, which may be proposed as a general mechanism for
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other ABC transporters of lipids and/or amphiphilic drugs
involved in mammalian physiology.
SUPPLEMENTARY MATERIAL
An online supplement to this article can be found by visiting
BJ Online at http://www.biophysj.org.
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